Tamara McGrillen | Head, IR |
Dr. Geert Cauwenbergh | President and CEO |
Dr. Gerrit Dispersyn | Chief Development Officer |
Caitlin Kontulis | Principal Accounting Officer |
John Vandermosten | Zacks Small Cap Research |
Good day ladies and gentlemen and welcome to the webcast entitled RXi Pharmaceuticals Fourth Quarter and Year End 2017 Financial Results Earning Call. Today's call is being recorded. At this time, it is my pleasure to turn the floor over to Head of Investor Relations for RXi, Tamara McGrillen. Ma'am, the floor is yours.
Thank you, Operator, and good afternoon ladies and gentlemen, and thank you for participating on our call today.